Celldex Therapeutics (CLDX) Non Operating Income (2010 - 2012)
Celldex Therapeutics (CLDX) posted quarterly Non Operating Income of $105000.0 for Q3 2012, down 27.08% year-over-year from $144000.0 in Q4 2011, and down 16.67% quarter-over-quarter from $126000.0 in Q2 2012.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Non Operating Income (2010 - 2012) Analysis & Trends
Celldex Therapeutics' Non Operating Income history runs 3 years deep, the most recent figure standing at $105000.0 for Q3 2012.
- In Q3 2012, Non Operating Income fell 27.08% year-over-year to $105000.0; the TTM figure through Sep 2012 stood at $525000.0 (down 75.99% YoY), while the FY2011 annual figure was $396000.0, down 92.47% from the prior year.
- Non Operating Income for Q3 2012 stood at $105000.0, down from $126000.0 in the prior quarter.
- The five-year high for Non Operating Income was $1.9 million in Q4 2010, with the low at $79000.0 in Q2 2011.
- The 3-year median for Non Operating Income is $114500.0 (2010), against an average of $293100.0.
- The sharpest annual moves came in 2011 and 2012: Non Operating Income sank 95.27% in 2011, then surged 144.05% in 2012.
- Celldex Therapeutics' Non Operating Income stood at $1.9 million in 2010, then tumbled by 95.27% to $89000.0 in 2011, then grew by 17.98% to $105000.0 in 2012.
- Business Quant data shows CLDX's Non Operating Income at $105000.0 in Q3 2012, $126000.0 in Q2 2012, and $205000.0 in Q1 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | -139.24 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | -53.64 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -51.63 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | - |
| 10 | Celldex Therapeutics | 3.07 Bn | 3.07 Bn | -2.57 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2012 | 105,000.00 |
| Jun 30, 2012 | 126,000.00 |
| Mar 31, 2012 | 205,000.00 |
| Dec 31, 2011 | 89,000.00 |
| Sep 30, 2011 | 144,000.00 |
| Jun 30, 2011 | 79,000.00 |
| Mar 31, 2011 | 84,000.00 |
| Dec 31, 2010 | 1.88 Mn |
| Sep 30, 2010 | 124,000.00 |
| Jun 30, 2010 | 95,000.00 |